title: Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients.
authors.forename: Krisztina
authors.initials: K
authors.lastname: Bencsik
authors.forename: Zsanett
authors.initials: Z
authors.lastname: Fricska-Nagy
authors.forename: Cecília
authors.initials: C
authors.lastname: Rajda
authors.forename: Judit
authors.initials: J
authors.lastname: Füvesi
authors.forename: Margit
authors.initials: M
authors.lastname: Török
authors.forename: László
authors.initials: L
authors.lastname: Vécsei
authors.forename: Tünde
authors.initials: T
authors.lastname: Csépány
authors.forename: Klotild
authors.initials: K
authors.lastname: Mátyás
authors.forename: Eniko
authors.initials: E
authors.lastname: Dobos
authors.forename: Csilla
authors.initials: C
authors.lastname: Rózsa
authors.forename: Judit
authors.initials: J
authors.lastname: Semjén
mesh_terms: D000328:Adult; D018450:Disease Progression; D004334:Drug Administration Schedule; D005260:Female; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D006814:Hungary; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000191:economics; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D055502:Secondary Prevention
chemical_list: D007155:Immunologic Factors